PMCB

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

PharmaCyte Biotech Inc

NASDAQ | PMCB

0.97

USD

$0.00

(

0.00%

)

At Close (As of Oct 21, 2025)

$6.66M

Market Cap

16.33

P/E Ratio

0.06

EPS

$2.42

52 Week High

$0.80

52 Week Low

HEALTHCARE

Sector

PMCB Chart

Recent Chart
Price Action

PMCB Technicals

Tags:

PMCB Earnings

Yearly Income Statement (As of Apr 30, 2025)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$4.4M
Selling General And Administrative $3.9M
Research And Development $438K
Operating Expenses $4.4M
Investment Income Net -
Net Interest Income $1.4M
Interest Income $1.4M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax $31M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $31M
Comprehensive Income Net Of Tax -
Ebit -$4.4T
Ebitda $31M
Net Income $31M

Revenue & Profitability

Earnings Performance

PMCB Financials

yearly Balance Sheet (As of Apr 30, 2025)

Field Value (USD)
Total Assets $55M
Total Current Assets $22M
Cash And Cash Equivalents At Carrying Value $15M
Cash And Short Term Investments $15M
Inventory -
Current Net Receivables $3.7M
Total Non Current Assets $33M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $1.5M
Intangible Assets Excluding Goodwill $1.5M
Goodwill -
Investments -
Long Term Investments $22M
Short Term Investments $366K
Other Current Assets $3.1M
Other Non Current Assets -
Total Liabilities $3.3M
Total Current Liabilities $2.9M
Current Accounts Payable $399K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $363K
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $2.5M
Other Non Current Liabilities -
Total Shareholder Equity $52M
Treasury Stock -
Retained Earnings -$85M
Common Stock $2.2K
Common Stock Shares Outstanding $7.3M

yearly Cash Flow (As of Apr 30, 2025)

Field Value (USD)
Operating Cashflow -$3M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $4
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$7M
Cashflow From Financing -$25M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $1.1M
Dividend Payout Common Stock $1.1M
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$25M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $31M

yearly Income Statement (As of Apr 30, 2025)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$4.4M
Selling General And Administrative $3.9M
Research And Development $438K
Operating Expenses $4.4M
Investment Income Net -
Net Interest Income $1.4M
Interest Income $1.4M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax $31M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $31M
Comprehensive Income Net Of Tax -
Ebit -$4.4T
Ebitda $31M
Net Income $31M

PMCB News

PMCB Profile

PharmaCyte Biotech Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

PharmaCyte Biotech Inc. (PMCB) is a clinical-stage biotechnology company headquartered in Laguna Hills, California, focused on developing cutting-edge cell therapies for cancer and diabetes. Utilizing its proprietary technology platform, the company aims to create transformative treatments that enhance patient outcomes and overall quality of life. With a strategic emphasis on advancing its clinical programs, PharmaCyte Biotech is well-positioned to make significant contributions to the rapidly evolving biopharmaceutical sector, potentially addressing unmet medical needs and driving value for investors.

BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.83%
$12.57
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
RANI
+26.66%
$2.85
GDXD
+29.73%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
BURU
-15.23%
$0.28
ADAP
-17.62%
$0.04
T
-0.26%
$26.03
AIRE
+61.36%
$0.72
NVTS
+16.64%
$17.10
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.27%
$13.38
DVLT
0.00%
$2.41
IBIO
+24.30%
$1.11
RIG
+0.45%
$3.30
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ETHD
-0.53%
$3.73
ABEV
-2.42%
$2.21
TSLA
-1.07%
$442.60
RF
+1.22%
$24.35
ABAT
+38.55%
$6.72
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.84%
$11.40
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
LAES
-8.46%
$5.93
VALE
-1.22%
$11.26
BTBT
-8.29%
$3.87
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
PFE
+0.64%
$24.85
QBTS
-6.36%
$32.21
IREN
-6.79%
$55.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
MARA
-3.18%
$20.07
HAL
+11.53%
$25.23
BBD
-2.21%
$3.30
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
DFLI
-3.96%
$1.21
AAPL
+0.38%
$263.26
NIO
-3.61%
$6.80
CLSK
-7.62%
$18.84
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.45%
$51.94
KO
+4.10%
$71.25
ORCL
-4.85%
$277.18
SNAP
+1.68%
$7.86
PBR
-1.06%
$11.56
AMC
+3.61%
$2.87
NOK
-1.92%
$5.60
GRAB
+0.53%
$5.67
SMR
-13.23%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.02%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
ETWO
0.00%
$3.30
RGTZ
+15.11%
$15.61
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
WTO
+2.93%
$0.06
MSN
+70.10%
$0.81
AG
-11.17%
$12.75
BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.83%
$12.57
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
RANI
+26.66%
$2.85
GDXD
+29.73%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
BURU
-15.23%
$0.28
ADAP
-17.62%
$0.04
T
-0.26%
$26.03
AIRE
+61.36%
$0.72
NVTS
+16.64%
$17.10
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.27%
$13.38
DVLT
0.00%
$2.41
IBIO
+24.30%
$1.11
RIG
+0.45%
$3.30
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ETHD
-0.53%
$3.73
ABEV
-2.42%
$2.21
TSLA
-1.07%
$442.60
RF
+1.22%
$24.35
ABAT
+38.55%
$6.72
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.84%
$11.40
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
LAES
-8.46%
$5.93
VALE
-1.22%
$11.26
BTBT
-8.29%
$3.87
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
PFE
+0.64%
$24.85
QBTS
-6.36%
$32.21
IREN
-6.79%
$55.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
MARA
-3.18%
$20.07
HAL
+11.53%
$25.23
BBD
-2.21%
$3.30
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
DFLI
-3.96%
$1.21
AAPL
+0.38%
$263.26
NIO
-3.61%
$6.80
CLSK
-7.62%
$18.84
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.45%
$51.94
KO
+4.10%
$71.25
ORCL
-4.85%
$277.18
SNAP
+1.68%
$7.86
PBR
-1.06%
$11.56
AMC
+3.61%
$2.87
NOK
-1.92%
$5.60
GRAB
+0.53%
$5.67
SMR
-13.23%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.02%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
ETWO
0.00%
$3.30
RGTZ
+15.11%
$15.61
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
WTO
+2.93%
$0.06
MSN
+70.10%
$0.81
AG
-11.17%
$12.75
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.